Next Generation Diabetes Therapy and Drug Delivery Market, Global Outlook and Forecast 2024-2030
Report ID
47275
Publisher
Market Monitor Global
Published Date
07-Feb
Delivery Format
PDF
No of Report Page
127
Editor's Rating
US $3,250.00
US $4,225.00
US $4,875.00
  • Report Details 
    This research report provides a comprehensive analysis of the Next Generation Diabetes Therapy and Drug Delivery market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Next Generation Diabetes Therapy and Drug Delivery market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Next Generation Diabetes Therapy and Drug Delivery, challenges faced by the industry, and potential opportunities for market players.
The global Next Generation Diabetes Therapy and Drug Delivery market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Next Generation Diabetes Therapy and Drug Delivery market presents opportunities for various stakeholders, including Diagnostic/Clinics, ICUs. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Next Generation Diabetes Therapy and Drug Delivery market. Additionally, the growing consumer demand present avenues for market expansion.
The global Next Generation Diabetes Therapy and Drug Delivery market was valued at US$ 1657.9 million in 2023 and is projected to reach US$ 7861.7 million by 2030, at a CAGR of 24.5% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Next Generation Diabetes Therapy and Drug Delivery market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Next Generation Diabetes Therapy and Drug Delivery market.
Market Overview: The report provides a comprehensive overview of the Next Generation Diabetes Therapy and Drug Delivery market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Inhalable Insulin, Oral Insulin), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Next Generation Diabetes Therapy and Drug Delivery market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Next Generation Diabetes Therapy and Drug Delivery market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Next Generation Diabetes Therapy and Drug Delivery market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments. 
Market Segmentation and Forecast: The report segment the Next Generation Diabetes Therapy and Drug Delivery market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Next Generation Diabetes Therapy and Drug Delivery market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Next Generation Diabetes Therapy and Drug Delivery market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Next Generation Diabetes Therapy and Drug Delivery, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Next Generation Diabetes Therapy and Drug Delivery market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Next Generation Diabetes Therapy and Drug Delivery market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
    Inhalable Insulin
    Oral Insulin
    Insulin Patches
    CGM Systems
    Artificial Pancreas
Market segment by Application
    Diagnostic/Clinics
    ICUs
    Home Healthcare
Global Next Generation Diabetes Therapy and Drug Delivery Market Segment Percentages, By Region and Country, 2023 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Major players covered
    Johnson & Johnson
    Abbott Laboratories
    Medtronic
    Sanofi
    Novo Nordisk
    MannKind Corporation
    Enteris BioPharma
    Dexcom
    Senseonics
    Medtech
    Synertech
    Zosano Pharma
    Relmada Therapeutics
    Eli Lilly and Company
    Transdermal Specialties
Outline of Major Chapters:
Chapter 1: Introduces the definition of Next Generation Diabetes Therapy and Drug Delivery, market overview.
Chapter 2: Global Next Generation Diabetes Therapy and Drug Delivery market size in revenue.
Chapter 3: Detailed analysis of Next Generation Diabetes Therapy and Drug Delivery company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Next Generation Diabetes Therapy and Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
  • Table Of Content 
    1 Introduction to Research & Analysis Reports
    1.1 Next Generation Diabetes Therapy and Drug Delivery Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Next Generation Diabetes Therapy and Drug Delivery Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Next Generation Diabetes Therapy and Drug Delivery Overall Market Size
    2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size: 2023 VS 2030
    2.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Size, Prospects & Forecasts: 2019-2030
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Next Generation Diabetes Therapy and Drug Delivery Players in Global Market
    3.2 Top Global Next Generation Diabetes Therapy and Drug Delivery Companies Ranked by Revenue
    3.3 Global Next Generation Diabetes Therapy and Drug Delivery Revenue by Companies
    3.4 Top 3 and Top 5 Next Generation Diabetes Therapy and Drug Delivery Companies in Global Market, by Revenue in 2023
    3.5 Global Companies Next Generation Diabetes Therapy and Drug Delivery Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Next Generation Diabetes Therapy and Drug Delivery Players in Global Market
        3.6.1 List of Global Tier 1 Next Generation Diabetes Therapy and Drug Delivery Companies
        3.6.2 List of Global Tier 2 and Tier 3 Next Generation Diabetes Therapy and Drug Delivery Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Next Generation Diabetes Therapy and Drug Delivery Market Size Markets, 2023 & 2030
        4.1.2 Inhalable Insulin
        4.1.3 Oral Insulin
        4.1.4 Insulin Patches
        4.1.5 CGM Systems
        4.1.6 Artificial Pancreas
    4.2 By Type - Global Next Generation Diabetes Therapy and Drug Delivery Revenue & Forecasts
        4.2.1 By Type - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, 2019-2024
        4.2.2 By Type - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, 2025-2030
        4.2.3 By Type - Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2019-2030
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Next Generation Diabetes Therapy and Drug Delivery Market Size, 2023 & 2030
        5.1.2 Diagnostic/Clinics
        5.1.3 ICUs
        5.1.4 Home Healthcare
    5.2 By Application - Global Next Generation Diabetes Therapy and Drug Delivery Revenue & Forecasts
        5.2.1 By Application - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, 2019-2024
        5.2.2 By Application - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, 2025-2030
        5.2.3 By Application - Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2019-2030
6 Sights by Region
    6.1 By Region - Global Next Generation Diabetes Therapy and Drug Delivery Market Size, 2023 & 2030
    6.2 By Region - Global Next Generation Diabetes Therapy and Drug Delivery Revenue & Forecasts
        6.2.1 By Region - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, 2019-2024
        6.2.2 By Region - Global Next Generation Diabetes Therapy and Drug Delivery Revenue, 2025-2030
        6.2.3 By Region - Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share, 2019-2030
    6.3 North America
        6.3.1 By Country - North America Next Generation Diabetes Therapy and Drug Delivery Revenue, 2019-2030
        6.3.2 US Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
        6.3.3 Canada Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
        6.3.4 Mexico Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
    6.4 Europe
        6.4.1 By Country - Europe Next Generation Diabetes Therapy and Drug Delivery Revenue, 2019-2030
        6.4.2 Germany Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
        6.4.3 France Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
        6.4.4 U.K. Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
        6.4.5 Italy Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
        6.4.6 Russia Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
        6.4.7 Nordic Countries Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
        6.4.8 Benelux Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
    6.5 Asia
        6.5.1 By Region - Asia Next Generation Diabetes Therapy and Drug Delivery Revenue, 2019-2030
        6.5.2 China Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
        6.5.3 Japan Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
        6.5.4 South Korea Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
        6.5.5 Southeast Asia Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
        6.5.6 India Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
    6.6 South America
        6.6.1 By Country - South America Next Generation Diabetes Therapy and Drug Delivery Revenue, 2019-2030
        6.6.2 Brazil Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
        6.6.3 Argentina Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Revenue, 2019-2030
        6.7.2 Turkey Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
        6.7.3 Israel Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
        6.7.4 Saudi Arabia Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
        6.7.5 UAE Next Generation Diabetes Therapy and Drug Delivery Market Size, 2019-2030
7 Next Generation Diabetes Therapy and Drug Delivery Companies Profiles
    7.1 Johnson & Johnson
        7.1.1 Johnson & Johnson Company Summary
        7.1.2 Johnson & Johnson Business Overview
        7.1.3 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
        7.1.4 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
        7.1.5 Johnson & Johnson Key News & Latest Developments
    7.2 Abbott Laboratories
        7.2.1 Abbott Laboratories Company Summary
        7.2.2 Abbott Laboratories Business Overview
        7.2.3 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
        7.2.4 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
        7.2.5 Abbott Laboratories Key News & Latest Developments
    7.3 Medtronic
        7.3.1 Medtronic Company Summary
        7.3.2 Medtronic Business Overview
        7.3.3 Medtronic Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
        7.3.4 Medtronic Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
        7.3.5 Medtronic Key News & Latest Developments
    7.4 Sanofi
        7.4.1 Sanofi Company Summary
        7.4.2 Sanofi Business Overview
        7.4.3 Sanofi Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
        7.4.4 Sanofi Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
        7.4.5 Sanofi Key News & Latest Developments
    7.5 Novo Nordisk
        7.5.1 Novo Nordisk Company Summary
        7.5.2 Novo Nordisk Business Overview
        7.5.3 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
        7.5.4 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
        7.5.5 Novo Nordisk Key News & Latest Developments
    7.6 MannKind Corporation
        7.6.1 MannKind Corporation Company Summary
        7.6.2 MannKind Corporation Business Overview
        7.6.3 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
        7.6.4 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
        7.6.5 MannKind Corporation Key News & Latest Developments
    7.7 Enteris BioPharma
        7.7.1 Enteris BioPharma Company Summary
        7.7.2 Enteris BioPharma Business Overview
        7.7.3 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
        7.7.4 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
        7.7.5 Enteris BioPharma Key News & Latest Developments
    7.8 Dexcom
        7.8.1 Dexcom Company Summary
        7.8.2 Dexcom Business Overview
        7.8.3 Dexcom Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
        7.8.4 Dexcom Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
        7.8.5 Dexcom Key News & Latest Developments
    7.9 Senseonics
        7.9.1 Senseonics Company Summary
        7.9.2 Senseonics Business Overview
        7.9.3 Senseonics Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
        7.9.4 Senseonics Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
        7.9.5 Senseonics Key News & Latest Developments
    7.10 Medtech
        7.10.1 Medtech Company Summary
        7.10.2 Medtech Business Overview
        7.10.3 Medtech Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
        7.10.4 Medtech Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
        7.10.5 Medtech Key News & Latest Developments
    7.11 Synertech
        7.11.1 Synertech Company Summary
        7.11.2 Synertech Business Overview
        7.11.3 Synertech Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
        7.11.4 Synertech Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
        7.11.5 Synertech Key News & Latest Developments
    7.12 Zosano Pharma
        7.12.1 Zosano Pharma Company Summary
        7.12.2 Zosano Pharma Business Overview
        7.12.3 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
        7.12.4 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
        7.12.5 Zosano Pharma Key News & Latest Developments
    7.13 Relmada Therapeutics
        7.13.1 Relmada Therapeutics Company Summary
        7.13.2 Relmada Therapeutics Business Overview
        7.13.3 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
        7.13.4 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
        7.13.5 Relmada Therapeutics Key News & Latest Developments
    7.14 Eli Lilly and Company
        7.14.1 Eli Lilly and Company Company Summary
        7.14.2 Eli Lilly and Company Business Overview
        7.14.3 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
        7.14.4 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
        7.14.5 Eli Lilly and Company Key News & Latest Developments
    7.15 Transdermal Specialties
        7.15.1 Transdermal Specialties Company Summary
        7.15.2 Transdermal Specialties Business Overview
        7.15.3 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Major Product Offerings
        7.15.4 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Revenue in Global Market (2019-2024)
        7.15.5 Transdermal Specialties Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
  • Inquiry Before Buying

    Inquiry Before Buying

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday
  • Request Sample

    Request For Sample

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday


Our Trusted Clients
cooper.fr
koronos
waldenmedical
unioncomm.co.kr
technopathclinicaldiagnostics
toho-titanium.co.jp
straubmedical
sew-eurodrive.de
medurifarms
naperol
nvent
network.ae
petronas
saeedghodran
polyworldsys
seedplanning.co.jp
kraton
ipms.fraunhofer.de
infanttech
httpswww.castel-freres
hintoninfo
hexcel
freightways.co.nz
excelitas
Acco
aspet
brand
bmc
elevate
europ-assistance


GET IN TOUCH
Phone: +1 (415) 315-9432
Phone: +91 86698 89536
Email: inquiry@wiredrelease.com
SHORT NAVIGATION
connect with us